Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the same
US9056106B2 · kind B2 · utility
13Cited by
22References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 14, 2010 |
| Grant date | Jun 16, 2015 |
| Priority date | — |
| Expiry date | Jul 20, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y304/21006
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates unit dose formulations of antidotes to anticoagulants targeting factor Xa. Disclosed herein are methods of stopping or preventing bleeding in a patient that is currently undergoing anticoagulant therapy with a factor Xa inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.